↓ Skip to main content

Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control

Overview of attention for article published in Pharmaceutical Research, January 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

policy
1 policy source
patent
1 patent
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
952 Dimensions

Readers on

mendeley
1119 Mendeley
citeulike
1 CiteULike
Title
Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control
Published in
Pharmaceutical Research, January 2008
DOI 10.1007/s11095-007-9511-1
Pubmed ID
Authors

Lawrence X. Yu

Abstract

The purpose of this paper is to discuss the pharmaceutical Quality by Design (QbD) and describe how it can be used to ensure pharmaceutical quality.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1,119 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 7 <1%
Germany 5 <1%
Switzerland 4 <1%
United Kingdom 3 <1%
Denmark 3 <1%
United States 2 <1%
Netherlands 2 <1%
Australia 2 <1%
Brazil 1 <1%
Other 5 <1%
Unknown 1085 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 236 21%
Student > Master 173 15%
Researcher 133 12%
Student > Bachelor 112 10%
Other 52 5%
Other 148 13%
Unknown 265 24%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 188 17%
Engineering 130 12%
Chemistry 101 9%
Agricultural and Biological Sciences 100 9%
Chemical Engineering 82 7%
Other 197 18%
Unknown 321 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2023.
All research outputs
#3,287,643
of 23,313,051 outputs
Outputs from Pharmaceutical Research
#214
of 2,888 outputs
Outputs of similar age
#13,908
of 158,383 outputs
Outputs of similar age from Pharmaceutical Research
#4
of 25 outputs
Altmetric has tracked 23,313,051 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,888 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,383 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.